StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
PDSBBullishAnalyst Target Updateanalyst
Medium materiality6/10

PDSB price target raised to $4 at B. Riley

Oct 30, 2026, 2:23 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Bullish analyst revision with high implied upside, tempered by the uncertainty of a single target and the absence of a prior target for comparison.

AI summary

What happened, with direct paths to the underlying reporting

B. Riley raised its target on PDS Biotechnology to $4; the cited share price was $1.52. The target implies substantial upside, though it is an analyst opinion and no prior target was provided.

  • B. Riley raised its PDSB target to $4 from an unspecified prior level.
  • Cited price: $1.52; target is not a guaranteed outcome.

Key facts

  1. 01

    Target: $4

  2. 02

    Posted price: $1.52

  3. 03

    Analyst firm: B.Riley Financial

  4. 04

    Analyst: Mayank Mamtani

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event